Analysis of Hemolytic Properties of Nanoparticles

Analysis of Hemolytic Properties of Nanoparticles

Standard Number ITA-1
Organization Nanotechnology Characterization Laboratory USA
Level National
Category Specification
Status
  • JAN 2009 Published
ABSTRACT
The hemolytic potential of all intravenously administered pharmaceuticals must be evaluated. Hemolysis (destruction of red blood cells) in vivo can lead to anemia, jaundice and other pathological conditions.